Y Yarden

2.2k total citations
15 papers, 1.7k citations indexed

About

Y Yarden is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Y Yarden has authored 15 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Y Yarden's work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Y Yarden is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Y Yarden collaborates with scholars based in Israel, United States and United Kingdom. Y Yarden's co-authors include Daniel Harari, Steven J. Burden, Ira Mellman, R A Weinberg, Sima Lev, David Givol, R Ben-Levy, Gideon Rechavi, Avi Orr‐Urtreger and Peter Lonai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Clinical Oncology.

In The Last Decade

Y Yarden

15 papers receiving 1.7k citations

Peers

Countries citing papers authored by Y Yarden

Since Specialization

Citations

This map shows the geographic impact of Y Yarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Yarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Yarden more than expected).

Fields of papers citing papers by Y Yarden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Yarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Yarden. The network helps show where Y Yarden may publish in the future.

Co-authorship network of co-authors of Y Yarden

This figure shows the co-authorship network connecting the top 25 collaborators of Y Yarden. A scholar is included among the top collaborators of Y Yarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Yarden. Y Yarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Endocytosis and Cancer 2013 ·Cold Spring Harbor Perspectives in Biology ·Ira Mellman, Y Yarden	302
2	Present and future breast cancer management—bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry 2013 ·Annals of Oncology ·Rupert Bartsch, S. Frings, (unknown), Ahmad Awada, Anna S. Berghoff, Pierfranco Conté, (unknown), Harald Enzmann, Michael Gnant, Max Hasmann, Hans R. Hendriks, Antonio Llombart‐Cussac, Cristian Massacesi, Gϋnter von Minckwitz, (unknown), Maurizio Scaltriti, Y Yarden, H. Zwierzina, Christoph Zielinski	7
3	Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression 2011 ·Oncogene ·Fresia Pareja, Daniela A. Ferraro, (unknown), Hadas Cohen‐Dvashi, (unknown), Sebastian Aulmann, Nir Ben‐Chetrit, Gur Pines, (unknown), Nicola Crosetto, Wolfgang J. Köstler, Sílvia Carvalho, Sara Lavi, Fernando Schmitt, (unknown), Zohar Yakhini, Hans‐Peter Sinn, G.B. Mills, Y Yarden	82
4	Differences in response of breast cancer molecular profiles of patients likely to respond to either tyrosine kinase inhibitors or to erbB targeted therapies 2004 ·Journal of Clinical Oncology ·Sarah Bacus, Bradley L. Smith, Y Yarden, Neil L. Spector	2
5	Molecular mechanisms underlying ErbB2/HER2 action in breast cancer 2000 ·Oncogene ·Daniel Harari, Y Yarden	463
6	Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis 1997 ·Neuron ·Steven J. Burden, Y Yarden	399
7	CONVERGENCE OF SIGNALING BY INTERLEUKIN-3, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND MAST CELL GROWTH FACTOR ON JAK2 TYROSINE KINASE 1994 ·Oncogene ·Maria Felice Brizzi, (unknown), (unknown), (unknown), Y Yarden, Luigi Pegoraro	1
8	Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase 1994 ·Cancer treatment and research ·Ilana Stancovski, Michael Sela, Y Yarden	25
9	Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. 1993 ·Proceedings of the National Academy of Sciences ·Avi Orr‐Urtreger, (unknown), R Ben-Levy, D Wen, Gideon Rechavi, Peter Lonai, Y Yarden	100
10	Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy 1992 ·The Journal of Steroid Biochemistry and Molecular Biology ·Ilana Stancovski, Elior Peles, (unknown), (unknown), Zvi Kelman, (unknown), Esther Hurwitz, Sarah Bacus, Michael Sela, Y Yarden	19
11	Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. 1992 ·Proceedings of the National Academy of Sciences ·Sima Lev, David Givol, Y Yarden	112
12	Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. 1990 ·Proceedings of the National Academy of Sciences ·Y Yarden	95
13	Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene. 1989 ·Proceedings of the National Academy of Sciences ·Y Yarden, R A Weinberg	102
14	Protein Kinases in Cellular Signal Transduction: Tyrosine Kinase Growth Factor Receptors and Protein Kinase C 1986 ·Cold Spring Harbor Symposia on Quantitative Biology ·A Ullrich, Heimo Riedel, Y Yarden, Lisa M. Coussens, Alexander Gray, Thomas J. Dull, Joseph Schlessinger, Michael D. Waterfield, Peter J. Parker	20
15	Phosphoamino acid specificity of the EGF-receptor kinase system in normal mitogenically responsive human cells 1983 ·Cell Biology International Reports ·Y Yarden, Joseph Schlessinger	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact